Published in Hepatitis Weekly, May 15th, 2006
"HCV is a global health problem and a leading cause of liver disease. Here, we demonstrate that the replication of HCV replicon RNA in Huh-7 cells is inhibited by a PPAR antagonist, 2-chloro-5-nitro-N-(pyridyl) benzamide (BA)," wrote B. Rakic and colleagues, National Research Council of Canada.
The authors wrote, "Downregulation of PPAR gamma with RNA interference approaches had no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.